Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice.
Dietary copper deficiency (CuD)(3) leads to cardiac hypertrophy in various animal models. We showed recently that heart failure develops after hypertrophy in FVB mice fed a CuD diet. The present study was undertaken to determine whether CuD-induced cardiac failure is reversible upon copper repletion (CuR). Dams of FVB mice were fed a CuD diet (0.3 mg/kg) starting from d 3 postdelivery; the weanling pups were fed the same diet until CuR with 6.0 mg/kg Cu in the diet at 4 or 5 wk of age. CuR at 4 wk of age prevented the body weight loss; at 5 wk of age, it resulted in the regaining of the lost weight caused by CuD. A significant regression of CuD-induced cardiac hypertrophy was observed in the CuR mice. Histopathological examination revealed that CuR eliminated CuD-caused lipid deposition in the myocardium, and electron microscopy demonstrated that CuD-induced ultrastructural changes such as mitochondrial swelling and organelle structural disarray were all reversed in the CuR mice. Hemodynamic analysis showed that the CuD-depressed systolic and diastolic parameters such as the maximal rate of left ventricular pressure rise (+dP/dt) and decline (-dP/dt), and the contraction and relaxation times were completely recovered in the CuR mice. Furthermore, the CuD-blunted myocardial responses to the beta-adrenergic agonist, isoproterenol, were also restored in the CuR mice. This study thus demonstrates for the first time that CuR results in the regression of heart failure induced by CuD as demonstrated by the reversal of depressed cardiac hemodynamic and contractile function and the restored responsiveness to beta-adrenergic stimulation.
Elsherif
Laila
L
Department of Pharmacology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Wang
Lipeng
L
Saari
Jack T
JT
Kang
Y James
YJ
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D009202:Cardiomyopathies / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D003300:Copper / Q000008:administration & dosage* / Q000172:deficiency*; D004032:Diet; D005260:Female; D006339:Heart Rate; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D008929:Mitochondria, Heart / Q000648:ultrastructure; D009200:Myocardial Contraction; D009206:Myocardium / Q000648:ultrastructure; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology
D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta; D003300:Copper; D007545:Isoproterenol